申请人:Hoffmann-La Roche Inc.
公开号:US20210300947A1
公开(公告)日:2021-09-30
The present invention relates to compounds of formula (I), ab (I), wherein R1 to R3 and L are as described herein, and their pharmaceutically acceptable salt, enantiomer or diastereomer thereof, and compositions including the compounds and methods of using the compounds.